Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Glioblastoma | 14 | 2019 | 3481 | 1.170 |
Why?
|
Brain Neoplasms | 24 | 2019 | 8863 | 1.100 |
Why?
|
Confusion | 2 | 2018 | 275 | 1.090 |
Why?
|
Inclusion Bodies | 6 | 2012 | 279 | 0.860 |
Why?
|
Receptors, Antigen, T-Cell | 2 | 2019 | 2540 | 0.680 |
Why?
|
Roseolovirus Infections | 1 | 2018 | 45 | 0.610 |
Why?
|
Meningoencephalitis | 1 | 2018 | 78 | 0.600 |
Why?
|
Herpesvirus 6, Human | 1 | 2018 | 95 | 0.600 |
Why?
|
Meningeal Neoplasms | 4 | 2019 | 1241 | 0.560 |
Why?
|
Giant Cell Tumors | 1 | 2016 | 99 | 0.530 |
Why?
|
Oligodendroglioma | 1 | 2017 | 279 | 0.530 |
Why?
|
Central Nervous System Neoplasms | 2 | 2019 | 895 | 0.470 |
Why?
|
Immunity, Cellular | 1 | 2019 | 1607 | 0.460 |
Why?
|
Immunotherapy, Adoptive | 2 | 2019 | 1270 | 0.450 |
Why?
|
Immunocompromised Host | 1 | 2018 | 847 | 0.430 |
Why?
|
World Health Organization | 1 | 2018 | 1318 | 0.410 |
Why?
|
DNA-Binding Proteins | 8 | 2012 | 9648 | 0.370 |
Why?
|
Frontotemporal Lobar Degeneration | 4 | 2013 | 99 | 0.370 |
Why?
|
Lymphoma | 1 | 2019 | 1877 | 0.360 |
Why?
|
Spastic Paraplegia, Hereditary | 1 | 2012 | 157 | 0.360 |
Why?
|
Amyotrophic Lateral Sclerosis | 6 | 2010 | 1414 | 0.360 |
Why?
|
Tissue Plasminogen Activator | 2 | 2006 | 1261 | 0.340 |
Why?
|
Headache | 1 | 2017 | 1226 | 0.340 |
Why?
|
Stem Cell Transplantation | 1 | 2018 | 1620 | 0.340 |
Why?
|
Motor Neuron Disease | 3 | 2009 | 99 | 0.340 |
Why?
|
Tumor Microenvironment | 3 | 2019 | 3586 | 0.340 |
Why?
|
Spinal Neoplasms | 1 | 2016 | 760 | 0.330 |
Why?
|
Spine | 1 | 2016 | 1144 | 0.330 |
Why?
|
Isocitrate Dehydrogenase | 3 | 2019 | 871 | 0.320 |
Why?
|
Dementia | 6 | 2009 | 2518 | 0.320 |
Why?
|
Complement System Proteins | 1 | 2011 | 795 | 0.310 |
Why?
|
Plasma Cells | 1 | 2011 | 591 | 0.310 |
Why?
|
Encephalitis | 1 | 2011 | 423 | 0.310 |
Why?
|
Seizures | 2 | 2017 | 2859 | 0.300 |
Why?
|
Ocular Motility Disorders | 1 | 2009 | 135 | 0.300 |
Why?
|
Intermediate Filaments | 1 | 2008 | 175 | 0.300 |
Why?
|
Glioma | 4 | 2019 | 3401 | 0.280 |
Why?
|
Parkinsonian Disorders | 2 | 2011 | 275 | 0.270 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 2011 | 895 | 0.270 |
Why?
|
Neoplasm Recurrence, Local | 5 | 2019 | 9239 | 0.270 |
Why?
|
Mutation | 16 | 2019 | 29786 | 0.270 |
Why?
|
Pituitary Neoplasms | 4 | 2019 | 1345 | 0.260 |
Why?
|
Meningioma | 3 | 2019 | 1209 | 0.260 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 2 | 2019 | 890 | 0.250 |
Why?
|
Craniopharyngioma | 2 | 2019 | 281 | 0.240 |
Why?
|
Spinal Cord | 1 | 2012 | 1809 | 0.240 |
Why?
|
Brain Infarction | 1 | 2006 | 299 | 0.230 |
Why?
|
Brain | 11 | 2019 | 26385 | 0.230 |
Why?
|
Neurons | 5 | 2013 | 9338 | 0.230 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2018 | 5442 | 0.220 |
Why?
|
Hemostasis | 1 | 2006 | 458 | 0.220 |
Why?
|
Image Interpretation, Computer-Assisted | 2 | 2015 | 3327 | 0.220 |
Why?
|
Membrane Proteins | 4 | 2015 | 7880 | 0.210 |
Why?
|
TOR Serine-Threonine Kinases | 3 | 2019 | 2109 | 0.200 |
Why?
|
Neurosurgical Procedures | 3 | 2017 | 2002 | 0.200 |
Why?
|
Autopsy | 2 | 2018 | 1020 | 0.200 |
Why?
|
Immunohistochemistry | 11 | 2019 | 11366 | 0.200 |
Why?
|
Radiation Injuries | 2 | 2019 | 1180 | 0.190 |
Why?
|
Disease Progression | 10 | 2019 | 13284 | 0.190 |
Why?
|
Intercellular Signaling Peptides and Proteins | 4 | 2013 | 1676 | 0.190 |
Why?
|
Male | 45 | 2019 | 350118 | 0.180 |
Why?
|
Middle Aged | 38 | 2019 | 213383 | 0.170 |
Why?
|
Fatal Outcome | 2 | 2018 | 1850 | 0.170 |
Why?
|
Surgery, Computer-Assisted | 2 | 2017 | 1018 | 0.170 |
Why?
|
Antigens, CD20 | 1 | 2019 | 199 | 0.170 |
Why?
|
Aged | 27 | 2019 | 163280 | 0.160 |
Why?
|
Foscarnet | 1 | 2018 | 38 | 0.160 |
Why?
|
Astrocytoma | 2 | 2013 | 790 | 0.160 |
Why?
|
Magnetic Resonance Imaging | 13 | 2018 | 35421 | 0.160 |
Why?
|
Neurocytoma | 1 | 2018 | 30 | 0.160 |
Why?
|
Diffusion Tensor Imaging | 3 | 2018 | 2305 | 0.160 |
Why?
|
Humans | 61 | 2019 | 744343 | 0.160 |
Why?
|
Graft vs Host Reaction | 1 | 2018 | 104 | 0.160 |
Why?
|
Antineoplastic Agents, Alkylating | 2 | 2019 | 627 | 0.160 |
Why?
|
Female | 45 | 2019 | 380194 | 0.150 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 3 | 2018 | 379 | 0.150 |
Why?
|
Folate Receptor 1 | 1 | 2017 | 36 | 0.150 |
Why?
|
Oxazines | 1 | 2019 | 298 | 0.150 |
Why?
|
Pyrimidines | 2 | 2019 | 2942 | 0.150 |
Why?
|
Dystrophin | 1 | 2018 | 285 | 0.150 |
Why?
|
Proto-Oncogene Proteins B-raf | 2 | 2019 | 2043 | 0.140 |
Why?
|
Thrombolytic Therapy | 1 | 2006 | 2161 | 0.140 |
Why?
|
Toxoplasmosis, Cerebral | 1 | 2016 | 18 | 0.140 |
Why?
|
ACTH-Secreting Pituitary Adenoma | 1 | 2016 | 61 | 0.140 |
Why?
|
Fibrinolytic Agents | 1 | 2006 | 2158 | 0.140 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2019 | 705 | 0.130 |
Why?
|
Neurotoxicity Syndromes | 1 | 2019 | 290 | 0.130 |
Why?
|
Adult | 26 | 2019 | 214055 | 0.130 |
Why?
|
AIDS Dementia Complex | 1 | 2016 | 154 | 0.130 |
Why?
|
Leukoencephalopathy, Progressive Multifocal | 1 | 2016 | 134 | 0.120 |
Why?
|
Spectroscopy, Near-Infrared | 2 | 2017 | 721 | 0.120 |
Why?
|
Myeloid Differentiation Factor 88 | 1 | 2019 | 571 | 0.120 |
Why?
|
Oligodendroglia | 1 | 2018 | 517 | 0.120 |
Why?
|
Cerebral Hemorrhage | 1 | 2006 | 2647 | 0.120 |
Why?
|
Cell-Derived Microparticles | 1 | 2016 | 168 | 0.120 |
Why?
|
Epilepsy, Temporal Lobe | 1 | 2018 | 403 | 0.120 |
Why?
|
Entorhinal Cortex | 1 | 2015 | 272 | 0.120 |
Why?
|
Young Adult | 12 | 2019 | 56430 | 0.120 |
Why?
|
Nerve Sheath Neoplasms | 1 | 2015 | 190 | 0.110 |
Why?
|
Algorithms | 2 | 2019 | 13881 | 0.110 |
Why?
|
Orbital Neoplasms | 1 | 2015 | 225 | 0.110 |
Why?
|
Beriberi | 1 | 2012 | 6 | 0.110 |
Why?
|
Struma Ovarii | 1 | 2012 | 10 | 0.110 |
Why?
|
Wernicke Encephalopathy | 1 | 2012 | 28 | 0.100 |
Why?
|
Oncogenes | 1 | 2018 | 1265 | 0.100 |
Why?
|
Complement Fixation Tests | 1 | 2011 | 78 | 0.100 |
Why?
|
Arrhythmogenic Right Ventricular Dysplasia | 1 | 2013 | 161 | 0.100 |
Why?
|
Antibody-Producing Cells | 1 | 2011 | 143 | 0.100 |
Why?
|
Diagnosis, Differential | 5 | 2019 | 12959 | 0.100 |
Why?
|
Thyroid Gland | 1 | 2018 | 1173 | 0.100 |
Why?
|
Cohort Studies | 11 | 2019 | 40561 | 0.100 |
Why?
|
Syndecan-1 | 1 | 2011 | 165 | 0.090 |
Why?
|
Gene Deletion | 1 | 2018 | 2751 | 0.090 |
Why?
|
Magnetic Resonance Angiography | 1 | 2017 | 1442 | 0.090 |
Why?
|
Neurofibromatosis 1 | 1 | 2015 | 569 | 0.090 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2019 | 2938 | 0.090 |
Why?
|
Biopsy | 3 | 2016 | 6756 | 0.090 |
Why?
|
Transplantation, Homologous | 1 | 2018 | 4776 | 0.090 |
Why?
|
Aged, 80 and over | 11 | 2019 | 57776 | 0.090 |
Why?
|
Chromosomes, Human, Pair 7 | 1 | 2010 | 322 | 0.080 |
Why?
|
Piperazines | 1 | 2019 | 2488 | 0.080 |
Why?
|
Blood-Brain Barrier | 1 | 2015 | 1017 | 0.080 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2019 | 1378 | 0.080 |
Why?
|
Chromosomes, Human, Pair 9 | 1 | 2010 | 535 | 0.080 |
Why?
|
Adolescent | 11 | 2019 | 85781 | 0.080 |
Why?
|
Retrospective Studies | 10 | 2019 | 77449 | 0.080 |
Why?
|
Teratoma | 1 | 2011 | 395 | 0.080 |
Why?
|
Treatment Outcome | 7 | 2019 | 63114 | 0.080 |
Why?
|
Amygdala | 1 | 2015 | 1315 | 0.080 |
Why?
|
DNA Helicases | 1 | 2013 | 859 | 0.080 |
Why?
|
Brain Chemistry | 1 | 2011 | 981 | 0.080 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2017 | 2942 | 0.070 |
Why?
|
Telomere | 1 | 2013 | 910 | 0.070 |
Why?
|
Pyramidal Tracts | 1 | 2009 | 256 | 0.070 |
Why?
|
Bulbar Palsy, Progressive | 1 | 2006 | 10 | 0.070 |
Why?
|
Motor Neurons | 2 | 2009 | 844 | 0.070 |
Why?
|
Protein Precursors | 1 | 2011 | 1154 | 0.070 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2018 | 1596 | 0.070 |
Why?
|
Adenoma | 1 | 2017 | 2174 | 0.070 |
Why?
|
Adenosine Triphosphatases | 1 | 2010 | 839 | 0.070 |
Why?
|
Genetic Markers | 2 | 2011 | 2634 | 0.070 |
Why?
|
Amino Acid Substitution | 1 | 2010 | 1791 | 0.070 |
Why?
|
Gangliosides | 1 | 2006 | 137 | 0.070 |
Why?
|
Endoscopy | 1 | 2015 | 1785 | 0.070 |
Why?
|
Antiviral Agents | 1 | 2018 | 2987 | 0.070 |
Why?
|
Indocyanine Green | 2 | 2017 | 239 | 0.060 |
Why?
|
Signal Transduction | 2 | 2019 | 23403 | 0.060 |
Why?
|
Cell Proliferation | 5 | 2019 | 10481 | 0.060 |
Why?
|
Fibrinolysis | 1 | 2006 | 322 | 0.060 |
Why?
|
Ovarian Neoplasms | 2 | 2012 | 4838 | 0.060 |
Why?
|
Exons | 1 | 2010 | 2437 | 0.060 |
Why?
|
Tachycardia, Ventricular | 1 | 2013 | 1273 | 0.060 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2015 | 2915 | 0.060 |
Why?
|
DNA Copy Number Variations | 1 | 2013 | 1941 | 0.060 |
Why?
|
Coloring Agents | 2 | 2017 | 566 | 0.060 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2016 | 2737 | 0.060 |
Why?
|
Antibody Specificity | 1 | 2006 | 1095 | 0.060 |
Why?
|
Thyroid Neoplasms | 2 | 2018 | 2282 | 0.060 |
Why?
|
Stroke | 1 | 2006 | 9981 | 0.060 |
Why?
|
DNA Mutational Analysis | 2 | 2009 | 4186 | 0.060 |
Why?
|
Hippocampus | 1 | 2015 | 3675 | 0.050 |
Why?
|
Bariatric Surgery | 1 | 2012 | 952 | 0.050 |
Why?
|
Medical Records | 1 | 2008 | 1413 | 0.050 |
Why?
|
Breast Neoplasms | 2 | 2019 | 20822 | 0.050 |
Why?
|
T-Lymphocytes | 1 | 2019 | 10180 | 0.050 |
Why?
|
Central Nervous System | 1 | 2009 | 1357 | 0.050 |
Why?
|
Cell Line, Tumor | 4 | 2019 | 16689 | 0.050 |
Why?
|
Neuroglia | 3 | 2013 | 927 | 0.050 |
Why?
|
Nerve Tissue Proteins | 1 | 2013 | 4462 | 0.050 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2015 | 5172 | 0.050 |
Why?
|
Electrocardiography | 1 | 2013 | 6442 | 0.040 |
Why?
|
Blood Coagulation | 1 | 2006 | 1127 | 0.040 |
Why?
|
Predictive Value of Tests | 3 | 2016 | 15076 | 0.040 |
Why?
|
Thyroidectomy | 2 | 2018 | 879 | 0.040 |
Why?
|
Follow-Up Studies | 4 | 2019 | 39050 | 0.040 |
Why?
|
Syndrome | 1 | 2006 | 3251 | 0.040 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2010 | 15519 | 0.040 |
Why?
|
Cell Cycle Proteins | 1 | 2010 | 3462 | 0.040 |
Why?
|
Sex Chromatin | 1 | 2018 | 20 | 0.040 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2016 | 8949 | 0.040 |
Why?
|
Protein Kinase Inhibitors | 3 | 2019 | 5535 | 0.040 |
Why?
|
Sensitivity and Specificity | 3 | 2019 | 14722 | 0.040 |
Why?
|
Single-Cell Analysis | 2 | 2019 | 2183 | 0.040 |
Why?
|
Nuclear Proteins | 1 | 2013 | 5853 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinase 7 | 1 | 2018 | 66 | 0.040 |
Why?
|
Neurofibromin 2 | 1 | 2019 | 267 | 0.040 |
Why?
|
Multivariate Analysis | 2 | 2015 | 12245 | 0.040 |
Why?
|
Genotype | 2 | 2010 | 12951 | 0.040 |
Why?
|
Sphenoid Sinus | 1 | 2017 | 99 | 0.040 |
Why?
|
Ganglioglioma | 1 | 2016 | 42 | 0.040 |
Why?
|
Neck Dissection | 1 | 2018 | 197 | 0.040 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2018 | 712 | 0.030 |
Why?
|
Infrared Rays | 1 | 2017 | 249 | 0.030 |
Why?
|
Recombinant Proteins | 1 | 2006 | 6622 | 0.030 |
Why?
|
Aminolevulinic Acid | 1 | 2016 | 142 | 0.030 |
Why?
|
Geography | 1 | 2018 | 669 | 0.030 |
Why?
|
Genetic Testing | 1 | 2009 | 3444 | 0.030 |
Why?
|
Genetic Heterogeneity | 1 | 2019 | 733 | 0.030 |
Why?
|
Dual Specificity Phosphatase 1 | 1 | 2015 | 44 | 0.030 |
Why?
|
Decompression | 1 | 2015 | 43 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinase Phosphatases | 1 | 2015 | 47 | 0.030 |
Why?
|
Cells, Cultured | 1 | 2011 | 19229 | 0.030 |
Why?
|
RNA, Messenger | 3 | 2018 | 13033 | 0.030 |
Why?
|
Dual-Specificity Phosphatases | 1 | 2015 | 73 | 0.030 |
Why?
|
Karnofsky Performance Status | 1 | 2015 | 173 | 0.030 |
Why?
|
Necrosis | 1 | 2019 | 1643 | 0.030 |
Why?
|
Rats | 1 | 2011 | 24260 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2019 | 1878 | 0.030 |
Why?
|
Atlases as Topic | 1 | 2016 | 236 | 0.030 |
Why?
|
Adrenocorticotropic Hormone | 1 | 2016 | 648 | 0.030 |
Why?
|
Exophthalmos | 1 | 2015 | 97 | 0.030 |
Why?
|
Gene Dosage | 1 | 2019 | 1252 | 0.030 |
Why?
|
Fluorescence | 1 | 2016 | 751 | 0.030 |
Why?
|
Pituitary ACTH Hypersecretion | 1 | 2016 | 175 | 0.030 |
Why?
|
Child | 5 | 2019 | 77709 | 0.030 |
Why?
|
Combined Modality Therapy | 2 | 2018 | 8642 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 2 | 2015 | 6538 | 0.030 |
Why?
|
Telomerase | 1 | 2018 | 730 | 0.030 |
Why?
|
Ubiquitin | 2 | 2009 | 852 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 3 | 2010 | 17446 | 0.030 |
Why?
|
Animals | 5 | 2019 | 168757 | 0.030 |
Why?
|
Biopsy, Fine-Needle | 1 | 2018 | 1094 | 0.030 |
Why?
|
Mice, Nude | 1 | 2019 | 3689 | 0.030 |
Why?
|
Apoptosis | 2 | 2019 | 9727 | 0.030 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2018 | 1770 | 0.030 |
Why?
|
Radiotherapy | 1 | 2019 | 1533 | 0.030 |
Why?
|
Orbit | 1 | 2015 | 426 | 0.030 |
Why?
|
Area Under Curve | 1 | 2016 | 1654 | 0.030 |
Why?
|
Prognosis | 3 | 2018 | 29063 | 0.030 |
Why?
|
Gadolinium | 1 | 2016 | 952 | 0.030 |
Why?
|
Tumor Cells, Cultured | 1 | 2019 | 6314 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2019 | 3557 | 0.020 |
Why?
|
Diagnostic Imaging | 1 | 2006 | 3507 | 0.020 |
Why?
|
Phenotype | 1 | 2019 | 16365 | 0.020 |
Why?
|
Mice | 4 | 2019 | 81183 | 0.020 |
Why?
|
Radiotherapy Dosage | 1 | 2018 | 2879 | 0.020 |
Why?
|
Tomography Scanners, X-Ray Computed | 1 | 2012 | 168 | 0.020 |
Why?
|
Cell Cycle | 1 | 2019 | 2967 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2015 | 2085 | 0.020 |
Why?
|
Craniotomy | 1 | 2015 | 729 | 0.020 |
Why?
|
Pericytes | 1 | 2013 | 292 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2009 | 3870 | 0.020 |
Why?
|
Child, Preschool | 2 | 2019 | 41006 | 0.020 |
Why?
|
Sequence Analysis, DNA | 2 | 2014 | 4803 | 0.020 |
Why?
|
Cell Lineage | 1 | 2019 | 2504 | 0.020 |
Why?
|
Disease Models, Animal | 2 | 2019 | 18029 | 0.020 |
Why?
|
NF-kappa B | 1 | 2019 | 2499 | 0.020 |
Why?
|
Postoperative Period | 1 | 2015 | 1842 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2018 | 2012 | 0.020 |
Why?
|
Information Dissemination | 1 | 2018 | 1099 | 0.020 |
Why?
|
North America | 1 | 2013 | 1249 | 0.020 |
Why?
|
Up-Regulation | 1 | 2019 | 4217 | 0.020 |
Why?
|
Ovariectomy | 1 | 2012 | 661 | 0.020 |
Why?
|
Fluorescent Dyes | 1 | 2017 | 1917 | 0.020 |
Why?
|
HIV Infections | 1 | 2016 | 16718 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2016 | 2373 | 0.020 |
Why?
|
Gene Amplification | 1 | 2013 | 1063 | 0.020 |
Why?
|
Cytoplasm | 1 | 2013 | 1539 | 0.020 |
Why?
|
beta Catenin | 1 | 2014 | 1059 | 0.020 |
Why?
|
Neoadjuvant Therapy | 1 | 2019 | 2728 | 0.020 |
Why?
|
Reoperation | 1 | 2018 | 4201 | 0.020 |
Why?
|
Hydrocortisone | 1 | 2016 | 1826 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2017 | 19905 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2006 | 15540 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2019 | 2727 | 0.020 |
Why?
|
Histones | 1 | 2018 | 2599 | 0.020 |
Why?
|
Occipital Lobe | 1 | 2009 | 379 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2018 | 6895 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2013 | 2886 | 0.020 |
Why?
|
Patient Selection | 1 | 2019 | 4215 | 0.020 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2013 | 2649 | 0.020 |
Why?
|
G(M3) Ganglioside | 1 | 2006 | 5 | 0.020 |
Why?
|
Computational Biology | 1 | 2019 | 3521 | 0.020 |
Why?
|
Carcinoma, Papillary | 1 | 2012 | 783 | 0.020 |
Why?
|
Immunoblotting | 1 | 2009 | 1682 | 0.020 |
Why?
|
Internet | 1 | 2018 | 3064 | 0.020 |
Why?
|
Alanine | 1 | 2008 | 572 | 0.020 |
Why?
|
Bayes Theorem | 1 | 2014 | 2309 | 0.020 |
Why?
|
Movement Disorders | 1 | 2009 | 445 | 0.020 |
Why?
|
Guideline Adherence | 1 | 2016 | 2266 | 0.020 |
Why?
|
Ultrasonography | 1 | 2018 | 5985 | 0.020 |
Why?
|
Linkage Disequilibrium | 1 | 2010 | 1997 | 0.020 |
Why?
|
Glycine | 1 | 2008 | 671 | 0.020 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2015 | 2948 | 0.020 |
Why?
|
Mutation, Missense | 1 | 2014 | 2564 | 0.020 |
Why?
|
Nerve Degeneration | 1 | 2009 | 748 | 0.020 |
Why?
|
Serine | 1 | 2008 | 826 | 0.020 |
Why?
|
Ubiquitination | 1 | 2009 | 1012 | 0.010 |
Why?
|
Risk Factors | 2 | 2013 | 72290 | 0.010 |
Why?
|
Phosphorylation | 1 | 2015 | 8436 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2019 | 8428 | 0.010 |
Why?
|
Contrast Media | 1 | 2016 | 5300 | 0.010 |
Why?
|
Reference Values | 1 | 2010 | 4982 | 0.010 |
Why?
|
Family Health | 1 | 2008 | 1282 | 0.010 |
Why?
|
Brain Mapping | 2 | 2009 | 6669 | 0.010 |
Why?
|
Gene Frequency | 1 | 2010 | 3588 | 0.010 |
Why?
|
Pedigree | 1 | 2010 | 4644 | 0.010 |
Why?
|
Survival Analysis | 1 | 2016 | 10252 | 0.010 |
Why?
|
Frontal Lobe | 1 | 2009 | 1406 | 0.010 |
Why?
|
Prospective Studies | 2 | 2017 | 53288 | 0.010 |
Why?
|
Case-Control Studies | 2 | 2010 | 21746 | 0.010 |
Why?
|
Base Sequence | 1 | 2014 | 12797 | 0.010 |
Why?
|
Cerebellum | 1 | 2009 | 1488 | 0.010 |
Why?
|
Temporal Lobe | 1 | 2009 | 1670 | 0.010 |
Why?
|
Survival Rate | 1 | 2016 | 12788 | 0.010 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2014 | 3597 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2019 | 21827 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2016 | 11031 | 0.010 |
Why?
|
Microglia | 1 | 2009 | 1266 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2014 | 18111 | 0.010 |
Why?
|
Endothelial Cells | 1 | 2013 | 3479 | 0.010 |
Why?
|
Carcinoma | 1 | 2012 | 2375 | 0.010 |
Why?
|
Evolution, Molecular | 1 | 2009 | 1940 | 0.010 |
Why?
|
Prevalence | 1 | 2016 | 15226 | 0.010 |
Why?
|
Sex Factors | 1 | 2013 | 10397 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2013 | 12354 | 0.010 |
Why?
|
Catheter Ablation | 1 | 2012 | 2758 | 0.010 |
Why?
|
Alleles | 1 | 2009 | 6933 | 0.010 |
Why?
|
Neural Pathways | 1 | 2009 | 2972 | 0.010 |
Why?
|
Infant | 1 | 2019 | 35136 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 2012 | 4931 | 0.010 |
Why?
|
Age Factors | 1 | 2013 | 18370 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2019 | 13695 | 0.010 |
Why?
|
Acute Disease | 1 | 2006 | 7149 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2018 | 20129 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2016 | 11524 | 0.010 |
Why?
|
Cognition Disorders | 1 | 2009 | 4043 | 0.010 |
Why?
|
Genetic Variation | 1 | 2009 | 6544 | 0.010 |
Why?
|
Alzheimer Disease | 1 | 2013 | 8037 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2008 | 13989 | 0.010 |
Why?
|
Time Factors | 1 | 2013 | 40075 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2010 | 12261 | 0.010 |
Why?
|
Obesity | 1 | 2012 | 12745 | 0.010 |
Why?
|